cells

ONK Therapeutics Presents Promising In-Vivo Data of its Optimized Affinity CD38 CAR-NK Candidate, Being Developed for the Treatment of Multiple Myeloma | DNA RNA and Cells

ONK Therapeutics Presents Promising In-Vivo Data of its Optimized Affinity CD38 CAR-NK Candidate, Being Developed for the Treatment of Multiple Myeloma Details Category: DNA RNA and Cells Published on Monday, 29 August 2022 13:24 Hits: 84 First in-vivo data for ONKT102, a fully human, optimized affinity CD38 CAR-NK cell therapy Data showed potent anti-tumor activity …

ONK Therapeutics Presents Promising In-Vivo Data of its Optimized Affinity CD38 CAR-NK Candidate, Being Developed for the Treatment of Multiple Myeloma | DNA RNA and Cells Read More »

DNA Repair-Kit Successfully Fixes Hereditary Disease in Cells

Genetic mutations which cause a debilitating hereditary kidney disease affecting children and young adults have been fixed in patient-derived kidney cells using a potentially game-changing DNA repair-kit. The advance, developed by University of Bristol scientists, is published in Nucleic Acids Research. In this new study, the international team describe how they created a DNA repair …

DNA Repair-Kit Successfully Fixes Hereditary Disease in Cells Read More »

BMW iX, i4 EVs Recall: Battery Fire Risks Detected on Car’s Power Cells, NHTSA Wants to Avoid Charging

BMW electric vehicles are now facing massive disputes on their use, especially with a detected battery fire risk by the NHTSA that may endanger the driver and passengers of the EV. A recall will roll out to its owners soon, and it would ask for the selected EVs from its owners to fix the issue …

BMW iX, i4 EVs Recall: Battery Fire Risks Detected on Car’s Power Cells, NHTSA Wants to Avoid Charging Read More »